Cowen and Company’s Agios Pharmaceuticals AGIO Stock Holding History

Cowen and Company’s Portfolio AGIO Stock Details AGIO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-30,000	Closed	-$718K	–	662
2022 Q2	$718K	Hold	30,000	–	–	0.07%	115
2022 Q1	$500K	Buy	30,000 +10,000	+50%	+$306K	0.05%	157
2021 Q4	$26K	Buy	+20,000	New	+$805K	﹤0.01%	501
2021 Q3	–	Sell	-68,400	Closed	-$68K	–	578
2021 Q2	$68K	Buy	68,400 +44,000	+180%	+$2.46M	﹤0.01%	373
2021 Q1	$74K	Buy	24,400 +14,400	+144%	+$713K	0.01%	350
2020 Q4	$26K	Buy	+10,000	New	+$395K	﹤0.01%	310
2020 Q1	–	Sell	-5,000	Closed	-$1K	–	411
2019 Q4	$1K	Sell	5,000 -36,200	-88%	-$1.37M	﹤0.01%	436
2019 Q3	$140K	Buy	+41,200	New	+$1.71M	0.04%	263

Other funds holding AGIO

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return

RSCM

Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return

Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Cowen and Company's AGIO Position: Q3 2022 in Review

Cowen and Company sold out of Agios Pharmaceuticals (AGIO) in Q3 2022, closing a stake of 27,132 shares — an estimated $602K sold.

Cowen and Company first reported a position in AGIO in Q3 2019 and held it in 4 quarters. The position peaked at $902K in Q3 2019. 168 funds tracked by Wall St. Rank hold AGIO as of Q3 2022.

Cowen and Company reported no remaining Agios Pharmaceuticals position as of Q3 2022 after selling out during the quarter.
Cowen and Company sold 27,132 Agios Pharmaceuticals shares in Q3 2022, an estimated $602K.
Cowen and Company first reported a position in Agios Pharmaceuticals in Q3 2019 and held it in 4 quarters.
Cowen and Company's Agios Pharmaceuticals position peaked at $902K in Q3 2019.
168 funds tracked by Wall St. Rank held Agios Pharmaceuticals as of Q3 2022.

Based on Cowen and Company's 13F filing for Q3 2022, filed 14 Nov 2022.